Legumain Protein as a Potential Predictive Biomarker for Asian Patients with Breast Carcinoma |
Wu, Mei
(Department of Radiology, The Second Hospital of Shandong University)
Shao, Guang-Rui (Department of Radiology, The Second Hospital of Shandong University) Zhang, Fei-Xue (Department of Radiology, The Second Hospital of Shandong University) Wu, Wen-Xiu (Department of Radiology, The Second Hospital of Shandong University) Xu, Ping (Department of Radiology, The Second Hospital of Shandong University) Ruan, Zheng-Min (Department of Radiology, The Second Hospital of Shandong University) |
1 | Asiaf A, Ahmad ST, Aziz SA, et al (2014). Loss of expression and abberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir. Asian Pac J Cancer Prev, 15, 6397-403. DOI |
2 | Casas A, Llombart A, Martin M (2013). Denosumab for the treatment of bone metastases in advanced breast cancer. Breast, 22, 585-92. DOI |
3 | Chen JM, Fortunato M, Stevens RA, et al (2001). Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase. Biol Chem, 382, 77-83. |
4 | Elzawawy A (2008). Breast cancer systemic therapy: the need for more economically sustainable scientific strategies in the world. Breast Care, 3, 434-8. |
5 | Gawenda J, Traub F, Luck HJ, et al (2007). Legumain expression as a prognostic factor in breast cancer patients. Breast Cancer Res Treat, 102, 1-6. DOI |
6 | Guo P, Zhu A, Sun Z, et al (2013). Expression of legumain correlates with prognosis and metastasis in gastric carcinoma. PLoS One, 8, 73090. DOI |
7 | Hu Q, Luo Z, Xu T, et al (2014). FOXA1: a promising prognostic marker in breast cancer. Asian Pac J Cancer Prev, 15, 11-6. DOI |
8 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
9 | Lewen A, Zhou H, Hu HD, et al (2008). A legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis. Cancer Immunol Immunother, 57, 507-15. DOI |
10 | Liu C, Sun X, Huang H, et al (2003). Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. Cancer Res, 63, 2957-64. |
11 | Luo Y, Zhou H, Krueger J, et al (2006). Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest, 116, 2132-41. DOI |
12 | Murthy RV, Arbman G, Gao J, et al (2005). Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer. Clin Cancer Res, 11, 2293-9. DOI |
13 | Parajuly SS, Lan PY, Yu MB, et al (2012). Diagnostic potential of strain ratio measurement and a 5 point scoring method for detection of breast cancer: Chinese experience. Asian Pac J Cancer Prev, 13, 1447-52. DOI ScienceOn |
14 | Reisfeld RA (2013). The tumor microenvironment: a target for combination therapy of breast cancer. Crit Rev Oncog, 18, 115-33. DOI |
15 | Rustogi A, Budrukkar A, Dinshaw K, et al (2005). Management of locally advanced breast cancer: evolution and current practice. J Cancer Res Ther, 1, 21-30. DOI |
16 | Santamaria ME, Hernandez-Crespo P, Ortego F, et al (2012). Cysteine peptidases and their inhibitors in Tetranychus urticae: a comparative genomic approach. BMC Genomics, 13, 307. DOI |
17 | Sevenich L, Schurigt U, Sachse K, et al (2010). Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice. Proc Natl Acad Sci USA, 107, 2497-502. DOI ScienceOn |
18 | Wang L, Chen S, Zhang M, et al (2012). Legumain: a biomarker for diagnosis and prognosis of human ovarian cancer. J Cell Biochem, 113, 2679-86. DOI |
19 | Taib NA, Akmal M, Mohamed I, Yip CH. (2011). Improvement in survival of breast cancer patients- trends over time periods in a single institution in an Asian Pacific country, Malaysia. Asian Pac J Cancer Prev, 12, 345-9. |
20 | Velaiutham S, Taib NA, Ng KL, Yoong BK, Yip CH (2008). Does the pre-operative value of serum CA15-3 correlate with survival in breast cancer. Asian Pac J Cancer Prev, 9, 445-8. |
21 | Wu W, Luo Y, Sun C, et al (2006). Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms. Cancer Res, 66, 970-80. DOI |
![]() |